Atypical Stimulants Analytical Standards Panel |
| Katalog-Nr.GC52282 |
For screening of atypical stimulants
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The Atypical Stimulants Analytical Standards Panel contains 126 analytical reference materials and standards categorized as atypical stimulants, including arylcyclohexylamines, piperazines, aminoindanes, opioids, nootropics, and precursors in the synthesis of stimulants. These compounds are supplied at 100 µg/well in a 96-well Matrix™ tube rack format for rapid screening or building in-house spectral libraries. The plate included in this panel contains a residual amount of glycerol to aid in the reconstitution of the analyte in methanol. Recovery in methanol has been validated for all analytes on the plate. Recovery from other solvents has not been verified. Please review the product insert for a full list of targets. The Atypical Stimulants Analytical Standards Panel contains compounds regulated as Schedule I-IV compounds in the United States and is regulated as a Schedule I item. This product is intended for research and forensic applications.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *